425: Strive CEO Posts on X.com Regarding Semler Merger

Strive, Inc. CEO Matthew Cole posted on X.com regarding the proposed business combination with Semler Scientific, Inc., accompanied by a cautionary statement on forward-looking information.

Summary

• Strive, Inc. CEO Matthew Cole posted on X.com on September 29, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication is a Form 425 filing, deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934.
• It includes a cautionary statement regarding forward-looking statements related to the proposed transaction, its strategic and financial benefits, timing, and integration.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, to register Class A common stock for the transaction and seek Semler Scientific stockholder approval.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when available for important information.

Sentiment

Score: 5

Explanation: The filing is a standard procedural communication regarding a proposed merger, heavily weighted with cautionary forward-looking statements and extensive risk disclosures. It is neutral in tone regarding the merger itself, but the emphasis on risks prevents a higher score.

Positives

• Anticipated strategic benefits of the proposed transaction.
• Expected financial benefits of the proposed transaction, including anticipated cost savings and strategic gains.

Negatives

• The filing is primarily a cautionary statement, highlighting numerous risks and uncertainties associated with the proposed merger, rather than explicit 'negatives' in terms of past performance or current issues. The risks section covers the potential downsides.

Risks

• Occurrence of any event, change, or circumstance that could lead to termination of the merger agreement.
• Possibility that the proposed transaction does not close as expected or at all due to unfulfilled conditions.
• Outcome of any legal proceedings against Strive or Semler Scientific or the combined company.
• Anticipated benefits, cost savings, and strategic gains may not be realized as expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and other digital assets.
• Impact of general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• Proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing outlines expectations for the proposed transaction, including strategic and financial benefits, successful integration, and the timing of closing. However, it heavily emphasizes that these are forward-looking statements subject to significant risks and uncertainties, and actual results may differ materially.

Management Comments

• Matthew Cole, CEO of Strive, Inc., posted on X.com on September 29, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

The proposed business combination between Strive and Semler Scientific reflects ongoing consolidation and strategic realignments within various sectors. The explicit mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' indicates a growing trend of companies exploring or integrating digital assets into their corporate finance strategies, which introduces new layers of financial and regulatory complexity.

Comparison to Industry Standards

• No specific comparable companies, projects, or results are mentioned in this filing to allow for a detailed comparison to industry standards. The filing is primarily procedural and risk-focused regarding a proposed merger.

Corporate Governance

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor for the proposed transaction.

Related Party Transactions

• Information regarding Semler Scientific's transactions with related persons is set forth in its definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders, filed on July 17, 2025.

Stakeholder Impact

• Potential adverse reactions from Strive's or Semler Scientific's customers due to the proposed transaction.
• Potential changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Dilution for existing shareholders of Strive due to the issuance of additional Class A common stock.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Strive Inc, Semler Scientific Inc, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Bitcoin Treasury, Digital Assets, Corporate Governance, Stockholder Approval